Kleiboeker, H. L., Jorgenson, M. R., Scolarici, M. J., Descourouez, J. L., Leverson, G. E., Saddler, C., . . . Al‐Adra, D. (2025). De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care. Wiley. https://doi.org/10.1111/ctr.70423
Chicago Style (17th ed.) CitationKleiboeker, Hanna L., Margaret R. Jorgenson, Michael J. Scolarici, Jillian L. Descourouez, Glen E. Leverson, Chris Saddler, Didier Mandlebrot, and David Al‐Adra. De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care. Wiley, 2025. https://doi.org/10.1111/ctr.70423.
MLA (9th ed.) CitationKleiboeker, Hanna L., et al. De Novo Letermovir After Cytomegalovirus Seropositive Kidney Transplant Improves Toxicity and Mycophenolate Tolerance Over the Current Standard of Care. Wiley, 2025. https://doi.org/10.1111/ctr.70423.